Automated Cell Culture Systems Market Outlook (2022-2030)

[250 Pages Report] Expanding at a high CAGR of 8.4%, the global automated cell culture systems market is projected to increase from a valuation of US$ 10.91 Billion in 2022 to US$ 20.87 Billion by 2030.

Automated cell culture systems currently account for 44.5% share in the global cell culture market. Expansion of the automated cell culture systems market is being fuelled by rising stem cell research and development, drug breakthroughs, and increased investments towards the development of innovative products.

Attribute Details
Automated Cell Culture Systems Market Size (2022) US$ 10.91 Billion
Revenue Forecast (2030) US$ 20.87 Billion
Global Market Growth Rate (2022 to 2030) 8.4% CAGR
Europe Marker Share 35.7%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

How The Market Progressed Till June 2022?

Particulars Details
H1, 2021 8.23%
H1, 2022 Projected 8.44%
H1, 2022 Outlook 8.24%
BPS Change - H1, 2022 (O) - H1, 2022 (P) (-) 20 ↓
BPS Change - H1, 2022 (O) - H1, 2021 (+) 01 ↑

H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 20 BPS. However, In H1-2022, the market growth rate of automated cell culture systems is expected to incline by 01 basis point share (BPS), as per FMI analysis.

The market for automated cell culture systems observes a decline in the BPS values due to the initial costs of automation and operational management. Moreover, equipment maintenance adds to additional cost overheads, thus proposing a hindrance to the overall market growth.

Although there are additional costs to automated cell culture systems, the future outlook is expected to be positive in terms of sales within the market. This is because automated systems can assist with bulk manufacturing of cell culture with management of cross contamination, within a closed system.

The key developments in the market include the advancement of the bioprocessing industry around the globe, especially within the South Asian region.

Automated Cell Culture System Demand Analysis (2015 to 2021) Vs Market Outlook (2022 to 2030)

In laboratories, automated cell culture instruments are used because they mechanically accomplish the duties needed in creating and sustaining a cell culture. These instruments are frequently employed in cytology laboratories.

Automated cell culture equipment can execute operations such as diluting samples, cultivating cultures in liquid with constant spinning, plating cultures, and placing cultures in wells. The capacity of automated cell culture systems to develop optimal cell lines across the entire range of seeding, feeding, massaging, and cell multiplication has gained in popularity.

Automated Cell Culture Systems Market

They help achieve strict standards demands while also decreasing contamination and human mistake. In the life sciences business, automated systems are employed for a variety of cell-based screening applications for both scientific and business purposes. The automated cell culture devices market expanded at a CAGR of 6.6% from 2015 to 2021.

Demand for automated cell culture equipment is increasing as the use of high-throughput cell lines in drug discovery research grows. The automated cell culture system demand is expected to progress at a CAGR of 8.4% from 2022 to 2030, with the global market predicted to reach a valuation of US$ 20.87 Bn by 2030.

Automated cell culture facilitates the production of large numbers of high-quality cell lines for pharmacological studies, resulting in improved product safety and efficacy. Other common scientific applications include RNA interference (RNAi), cell-based drug transport, metabolism, and toxicology studies.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

How is the Automated Cell Culture Systems Market Evolving?

“Development of Novel 3D Cell Culture Techniques & Growing Need of Cell Culture Technology”

Development of novel three-dimensional cell culture techniques, as well as the increased demand for these techniques in biopharmaceutical research and vaccine production, is driving the market for automated cell culture systems.

The benefits of cell-based vaccinations are becoming more widely recognized. Researchers and manufacturers have been pushed to develop automated cell culture-based immunizations by increased global demand for novel vaccines to restrict and cure the coronavirus's transmission, as well as strict safety standards.

“Advancement in Technologies Driving Consumption of Automated Cell Culture Systems”

High-throughput screening technology has shown to be indispensable, particularly when a huge number of biological/chemical substances are being examined to treat a specific condition.

As a result, the automated cell culture systems market is expected to be driven by the use of automation and robots for speedy assessment of biochemical or biological activities.

Which Regional Market Should Automated Cell Culture System Suppliers Concentrate On?

“High Investments in R&D of Oncology Driving Europe Automated Cell Culture Systems Market Growth”

The global automated cell culture equipment market has been studied across North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA).

North America and Europe regional markets account for more than half of the global market share for automated cell culture systems. This could be related to a rise in the use of automated cell culture vessels as a result of an increase in oncology research and drug development.

The presence of excellent laboratory facilities is also likely to help these two regions to stand out. In 2022, North America is expected to account for 25.1% and Europe is likely to hold 35.7% of the global market share.

Given the growing demand for cell-based medicine delivery, East Asia will be the most attractive market for automated cell culture products. East Asia currently is likely to account for 20.9% of the global market share.

In 2022, South Asia & Oceania together may account for 14.2% of the global market share. This is due to the technological innovations such as next-generation sequencing, increased awareness, increased healthcare expenditure in national budgets, early availability of modern technologies, and fast-developing of research activities across the region.

The Latin America & MEA automated cell culture systems markets are expected to progress at a slightly slower rate than other regions but are expected to pick up pace towards the end of the projection period. At present, Latin America & MEA are predicted to account for 2.4% & 1.5% of the global market share, respectively.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Analysis

Why is Demand for Automated Cell Culture Systems Surging in China?

“Rising Cases of Cancer Driving Sales of Automated Cell Culture Systems”

Because of government assistance and strategic initiatives, the China automated cell culture systems market is expected to grow rapidly. To cater for the enormous patient population, China is putting a larger emphasis on technological advancements.

A high need for innovative therapies and solutions has arisen due to an increase in the number of elderly people as well as a high cancer incidence. Progress in the field of regenerative medicine, as well as well-developed sophisticated healthcare systems, are driving automated cell culture systems market expansion in China.

Which Factors are Supporting Growth of the Automated Cell Culture Systems Market in the U.S.?

“High Spending on Healthcare Facilities Augmenting Sales Growth of Automated Cell Culture Systems”

The United States currently dominates the North America automated cell culture systems market, and this trend is likely to continue over the projection period. Growing demand for customized medications, as well as the existence of prominent companies in the market, is largely responsible for the market expansion.

Additionally, because healthcare is one of the country's top objectives, the US government is supportive of medical research. Increasing investments in the biomedical engineering industry are also boosting the country's market growth.

Category-wise Analysis

Which End User is Driving Substantial Automated Cell Culture Systems Market Growth?

“Improved Technologies & Increasing Funding in R&D Boost Sales of Biotech Companies”

Over the projected period, biotech companies are expected to progress at a fast pace. The presence of a significant number of biotechnology companies, an increase in R&D investment in these firms, and a greater demand for alternative testing methods over animal techniques are all primary market drivers.

3D cell culture has advantages over 2D cell culture in terms of suitable oxygen and nutritional gradients, non-uniform cell-to-cell contacts, and realistic cell-to-cell interactions. Because of these factors, 3D cell culture is more suitable for drug discovery and advancement, leading in rising demand for automated cell culture systems.

COVID-19 Impact on Market

The COVID-19 pandemic impacted a wide range of industries all across the world. Manufacturing facilities were shut down during the early stages of the pandemic. Furthermore, the financial collapse that followed the pandemic caused a significant delay in the healthcare industry's development.

Local producers and innovators, on the other hand, have a lot of opportunities in the automated cell culture systems market to develop cost-effective automated cell culture products. Demand for diagnostic and therapeutic facilities is steadily increasing, which may prompt a slew of new firms to enter the market with innovative products.

The COVID-19 pandemic is projected to tip the market in favour of automated cell culture systems, because research operations to generate efficient and effective COVID-19 vaccinations necessitate cell lines. Even once a suitable vaccine has been discovered, demand for cell lines will continue to rise as research in this field progresses.

Competitive Landscape

Manufacturers of automated cell culture systems have been heavily investing in research to develop long-term solutions for both, biopharmaceutical and packaging industries. Sustainable vessel solutions are primarily made up of recyclable plastics and glass bottles.

Recycling, on the other hand, is not without its difficulties. Recycling a multi-layer flexible vessel with barrier material and base material plastic is a time-consuming task.

As a result, companies are actively investing in research aimed at making the recycling process easier. Automated cell culture systems market players are also concentrating on innovations and collaborations to enhance their market presence.

Some of the market players included in this report are Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza Group Ltd, Sartorius AG, Tecan Trading AG, Hamilton Medical AG, Biospherix, and Promocell GmbH.

Automated Cell Culture Systems Industry Report Scope

Attribute Details
Forecast Period 2022 to 2030
Historical Data Available for 2015 to 2021
Market Analysis US$ Billion for Value
Key Regions Covered
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)
Key Countries Covered
  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • Turkey
  • South Africa
  • and GCC Countries
Key Market Segments Covered
  • Product
  • Cell Culture
  • Application
  • End User
  • Region
Key Companies Profiled
Pricing Available upon Request

Key Segments of Automated Cell Culture Systems Industry Survey

Automated Cell Culture Systems Market by Product:

  • Automated Cell Culture Storage Equipment
  • Automated Cell Culture Vessels
  • Bioreactors
  • Consumables

Automated Cell Culture Systems Market by Cell Culture:

  • Finite Cell Line Cultures
  • Infinite Cell Line Cultures

Automated Cell Culture Systems Market by Application:

  • Drug Development
  • Stem Cell Research
  • Regenerative Medicine
  • Cancer Research

Automated Cell Culture Systems Market by End User:

  • Biotech Companies
  • Research Organizations
  • Academic Institutes

Automated Cell Culture Systems Market by Region:

  • North America Automated Cell Culture Systems Market
  • Latin America Automated Cell Culture Systems Market
  • Europe Automated Cell Culture Systems Market
  • East Asia Automated Cell Culture Systems Market
  • South Asia & Pacific Automated Cell Culture Systems Market
  • Middle East & Africa (MEA) Automated Cell Culture Systems Market

Frequently Asked Questions

At what pace is the automated cell culture systems market expected to increase over the coming years?

The global automated cell culture systems market is predicted to progress at a high CAGR of 8.4% from 2022 to 2030.

At present, what valuation does the automated cell culture systems market enjoy?

The global market for automated cell culture systems is currently worth US$ 10.91 Bn.

Which prime automated cell culture systems market players are profiled in this analysis?

Key suppliers of automated cell culture systems are Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza Group Ltd, Sartorius AG, Tecan Trading AG, Hamilton Medical AG, Biospherix, and Promocell GmbH.

What is the automated cell culture systems market predicted to be worth by 2030?

By the end of 2030, automated cell culture system demand is anticipated to attain a market valuation of US$ 20.87 Bn.

What market share is held by Europe?

The Europe automated cell culture systems market currently holds 35.7% share in the global market.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand Side Trends
    1.3. Supply Side Trends
    1.4. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
    2.3. Inclusions and Exclusions
3. Key Market Trends
    3.1. Key Trends Impacting the Market
    3.2. Service Innovation / Development Trends
4. Market Background
    4.1. Macro-Economic Factors
        4.1.1. Global GDP Growth Outlook
        4.1.2. Global Healthcare Outlook
        4.1.3. Global Life Science Market Outlook
    4.2. Forecast Factors - Relevance & Impact
        4.2.1. Technology Development
        4.2.2. End User Demand
        4.2.3. Regulatory Imposition
        4.2.4. Technology Shortcomings
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunity
    4.4. COVID19 Crisis Analysis
        4.4.1. Current COVID19 Statistics and Probable Future Impact
        4.4.2. Current GDP Projection and Probable Impact
        4.4.3. Current Economic Projection as compared to 2008 Economic analysis
        4.4.4. COVID19 and Impact Analysis
            4.4.4.1. Revenue By Service
            4.4.4.2. Revenue By Country
        4.4.5. 2022 Market Scenario
        4.4.6. Quarter by Quarter Forecast
        4.4.7. Projected recovery Quarter
        4.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact
5. Market Context
    5.1. Regulatory Scenario
    5.2. Value Chain Analysis
    5.3. Key Strategies Adopted By Application Service Providers
    5.4. Technology Adoption Analysis
6. Global Automated Cell Culture Systems Market Value (US$ Mn) Analysis 2015-2021 and Forecast, 2022-2030
    6.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
    6.2. Current and Future Market Value (US$ Mn) Projections, 2022-2030
        6.2.1. Y-o-Y Growth Trend Analysis
        6.2.2. Opportunity Analysis, 2022-2030
7. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, By Product Type
    7.1. Introduction / Key Findings
    7.2. Historical Market Size (US$ Mn) By Product Type, 2015–2021
    7.3. Current and Future Market Size (US$ Mn) and Forecast By Product Type, 2022-2030
        7.3.1. Automated Cell Culture Storage Equipment
        7.3.2. Automated Cell Culture Vessels
        7.3.3. Bioreactors
        7.3.4. Consumables
    7.4. Market Attractiveness Analysis By Product Type
8. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, By Cell Culture Type
    8.1. Introduction / Key Findings
    8.2. Historical Market Size (US$ Mn) Analysis By Cell Culture Type, 2015–2021
    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cell Culture Type, 2022-2030
        8.3.1. Finite Cell Line Cultures
        8.3.2. Infinite Cell Line Cultures
    8.4. Market Attractiveness Analysis By Cell Culture Type
9. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, By Application
    9.1. Introduction / Key Findings
    9.2. Historical Market Size (US$ Mn) Analysis By Application, 2015–2021
    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2030
        9.3.1. Drug Development
        9.3.2. Stem Cell Research
        9.3.3. Regenerative Medicine
        9.3.4. Cancer Research
    9.4. Market Attractiveness Analysis By Application
10. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, by End User
    10.1. Introduction / Key Findings
    10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015–2021
    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2030
        10.3.1. Biotech Companies
        10.3.2. Research Organizations
        10.3.3. Academic Institutes
    10.4. Market Attractiveness Analysis By End User
11. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, by Region
    11.1. Introduction / Key Findings
    11.2. Historical Market Size (US$ Mn) By Region, 2015–2021
    11.3. Current and Future Market Size (US$ Mn) and Forecast By Region, 2022-2030
        11.3.1. North America
        11.3.2. Latin America
        11.3.3. Europe
        11.3.4. East Asia
        11.3.5. South Asia
        11.3.6. Oceania
        11.3.7. Middle East and Africa
    11.4. Market Attractiveness Analysis By Region
12. North America Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030
    12.1. Introduction
    12.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021
    12.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030
        12.3.1. By Country
            12.3.1.1. U.S.
            12.3.1.2. Canada
        12.3.2. By Product Type
        12.3.3. By Cell Culture Type
        12.3.4. By Application
        12.3.5. By End User
    12.4. Market Attractiveness Analysis
    12.5. Key Market Participants - Intensity Mapping
    12.6. Drivers and Restraints - Impact Analysis
13. Latin America Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030
    13.1. Introduction
    13.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021
    13.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030
        13.3.1. By Country
            13.3.1.1. Brazil
            13.3.1.2. Mexico
            13.3.1.3. Argentina
            13.3.1.4. Rest of Latin America
        13.3.2. By Product Type
        13.3.3. By Cell Culture Type
        13.3.4. By Application
        13.3.5. By End User
    13.4. Market Attractiveness Analysis
    13.5. Key Market Participants - Intensity Mapping
    13.6. Drivers and Restraints - Impact Analysis
14. Europe Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030
    14.1. Introduction
    14.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021
    14.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030
        14.3.1. By Country
            14.3.1.1. Germany
            14.3.1.2. Italy
            14.3.1.3. France
            14.3.1.4. U.K.
            14.3.1.5. Spain
            14.3.1.6. BENELUX
            14.3.1.7. Russia
            14.3.1.8. Rest of Europe
        14.3.2. By Product Type
        14.3.3. By Cell Culture Type
        14.3.4. By Application
        14.3.5. By End User
    14.4. Market Attractiveness Analysis
    14.5. Key Market Participants - Intensity Mapping
    14.6. Drivers and Restraints - Impact Analysis
15. South Asia Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030
    15.1. Introduction
    15.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021
    15.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030
        15.3.1. By Country
            15.3.1.1. India
            15.3.1.2. Thailand
            15.3.1.3. Indonesia
            15.3.1.4. Malaysia
            15.3.1.5. Rest of South Asia
        15.3.2. By Product Type
        15.3.3. By Cell Culture Type
        15.3.4. By Application
        15.3.5. By End User
    15.4. Market Attractiveness Analysis
    15.5. Key Market Participants - Intensity Mapping
    15.6. Drivers and Restraints - Impact Analysis
16. East Asia Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030
    16.1. Introduction
    16.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021
    16.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030
        16.3.1. By Country
            16.3.1.1. China
            16.3.1.2. Japan
            16.3.1.3. South Korea
        16.3.2. By Product Type
        16.3.3. By Cell Culture Type
        16.3.4. By Application
        16.3.5. By End User
    16.4. Market Attractiveness Analysis
    16.5. Key Market Participants - Intensity Mapping
    16.6. Drivers and Restraints - Impact Analysis
17. Oceania Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030
    17.1. Introduction
    17.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021
    17.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030
        17.3.1. By Country
            17.3.1.1. Australia
            17.3.1.2. New Zealand
        17.3.2. By Product Type
        17.3.3. By Cell Culture Type
        17.3.4. By Application
        17.3.5. By End User
    17.4. Market Attractiveness Analysis
    17.5. Key Market Participants - Intensity Mapping
    17.6. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030
    18.1. Introduction
    18.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021
    18.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030
        18.3.1. By Country
            18.3.1.1. GCC Countries
            18.3.1.2. Turkey
            18.3.1.3. South Africa
            18.3.1.4. Rest of Middle East and Africa
        18.3.2. By Product Type
        18.3.3. By Cell Culture Type
        18.3.4. By Application
        18.3.5. By End User
    18.4. Market Attractiveness Analysis
    18.5. Key Market Participants - Intensity Mapping
    18.6. Drivers and Restraints - Impact Analysis
19. Emerging & Key Countries Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030
    19.1. U.S. Automated Cell Culture Systems Market Analysis
        19.1.1. By Product Type
        19.1.2. By Cell Culture Type
        19.1.3. By Application
        19.1.4. By End User
    19.2. Canada Automated Cell Culture Systems Market Analysis
        19.2.1. By Product Type
        19.2.2. By Cell Culture Type
        19.2.3. By Application
        19.2.4. By End User
    19.3. Mexico Automated Cell Culture Systems Market Analysis
        19.3.1. By Product Type
        19.3.2. By Cell Culture Type
        19.3.3. By Application
        19.3.4. By End User
    19.4. Brazil Automated Cell Culture Systems Market Analysis
        19.4.1. By Product Type
        19.4.2. By Cell Culture Type
        19.4.3. By Application
        19.4.4. By End User
    19.5. U.K. Automated Cell Culture Systems Market Analysis
        19.5.1. By Product Type
        19.5.2. By Cell Culture Type
        19.5.3. By Application
        19.5.4. By End User
    19.6. Germany Automated Cell Culture Systems Market Analysis
        19.6.1. By Product Type
        19.6.2. By Cell Culture Type
        19.6.3. By Application
        19.6.4. By End User
    19.7. France Automated Cell Culture Systems Market Analysis
        19.7.1. By Product Type
        19.7.2. By Cell Culture Type
        19.7.3. By Application
        19.7.4. By End User
    19.8. Italy Automated Cell Culture Systems Market Analysis
        19.8.1. By Product Type
        19.8.2. By Cell Culture Type
        19.8.3. By Application
        19.8.4. By End User
    19.9. Spain Automated Cell Culture Systems Market Analysis
        19.9.1. By Product Type
        19.9.2. By Cell Culture Type
        19.9.3. By Application
        19.9.4. By End User
    19.10. BENELUX Automated Cell Culture Systems Market Analysis
        19.10.1. By Product Type
        19.10.2. By Cell Culture Type
        19.10.3. By Application
        19.10.4. By End User
    19.11. Russia Automated Cell Culture Systems Market Analysis
        19.11.1. By Product Type
        19.11.2. By Cell Culture Type
        19.11.3. By Application
        19.11.4. By End User
    19.12. China Automated Cell Culture Systems Market Analysis
        19.12.1. By Product Type
        19.12.2. By Cell Culture Type
        19.12.3. By Application
        19.12.4. By End User
    19.13. India Automated Cell Culture Systems Market Analysis
        19.13.1. By Product Type
        19.13.2. By Cell Culture Type
        19.13.3. By Application
        19.13.4. By End User
    19.14. Japan Automated Cell Culture Systems Market Analysis
        19.14.1. By Product Type
        19.14.2. By Cell Culture Type
        19.14.3. By Application
        19.14.4. By End User
    19.15. South Korea Automated Cell Culture Systems Market Analysis
        19.15.1. By Product Type
        19.15.2. By Cell Culture Type
        19.15.3. By Application
        19.15.4. By End User
    19.16. ASEAN Automated Cell Culture Systems Market Analysis
        19.16.1. By Product Type
        19.16.2. By Cell Culture Type
        19.16.3. By Application
        19.16.4. By End User
    19.17. Australia Automated Cell Culture Systems Market Analysis
        19.17.1. By Product Type
        19.17.2. By Cell Culture Type
        19.17.3. By Application
        19.17.4. By End User
    19.18. New Zealand Automated Cell Culture Systems Market Analysis
        19.18.1. By Product Type
        19.18.2. By Cell Culture Type
        19.18.3. By Application
        19.18.4. By End User
    19.19. GCC Countries Automated Cell Culture Systems Market Analysis
        19.19.1. By Product Type
        19.19.2. By Cell Culture Type
        19.19.3. By Application
        19.19.4. By End User
    19.20. Turkey Automated Cell Culture Systems Market Analysis
        19.20.1. By Product Type
        19.20.2. By Cell Culture Type
        19.20.3. By Application
        19.20.4. By End User
    19.21. South Africa Automated Cell Culture Systems Market Analysis
        19.21.1. By Product Type
        19.21.2. By Cell Culture Type
        19.21.3. By Application
        19.21.4. By End User
20. Market Structure Analysis
    20.1. Market Analysis by Tier of Companies
    20.2. Market Share Analysis of Top Players
    20.3. Market Presence Analysis
        20.3.1. Regional Footprint by Players
        20.3.2. Service Foot print by Players
        20.3.3. Channel Foot Print by Players
21. Competition Analysis
    21.1. Competition Dashboard
    21.2. Competition Benchmarking
    21.3. Competition Deep Dive (Tentative List)
        21.3.1. Thermo Fisher Scientific
            21.3.1.1. Overview
            21.3.1.2. Service Portfolio
            21.3.1.3. Profitability by Market Segments(Service/Channel/Country)
            21.3.1.4. Service Footprint
            21.3.1.5. Strategy Overview
                21.3.1.5.1. Marketing Strategy
                21.3.1.5.2. Service Strategy
                21.3.1.5.3. Channel Strategy
        21.3.2. Corning Incorporated
            21.3.2.1. Overview
            21.3.2.2. Service Portfolio
            21.3.2.3. Profitability by Market Segments(Service/Channel/Country)
            21.3.2.4. Service Footprint
            21.3.2.5. Strategy Overview
                21.3.2.5.1. Marketing Strategy
                21.3.2.5.2. Service Strategy
                21.3.2.5.3. Channel Strategy
        21.3.3. Merck KGaA
            21.3.3.1. Overview
            21.3.3.2. Service Portfolio
            21.3.3.3. Profitability by Market Segments(Service/Channel/Country)
            21.3.3.4. Service Footprint
            21.3.3.5. Strategy Overview
                21.3.3.5.1. Marketing Strategy
                21.3.3.5.2. Service Strategy
                21.3.3.5.3. Channel Strategy
        21.3.4. Lonza Group Ltd
            21.3.4.1. Overview
            21.3.4.2. Service Portfolio
            21.3.4.3. Profitability by Market Segments(Service/Channel/Country)
            21.3.4.4. Service Footprint
            21.3.4.5. Strategy Overview
                21.3.4.5.1. Marketing Strategy
                21.3.4.5.2. Service Strategy
                21.3.4.5.3. Channel Strategy
        21.3.5. Sartorius AG
            21.3.5.1. Overview
            21.3.5.2. Service Portfolio
            21.3.5.3. Profitability by Market Segments(Service/Channel/Country)
            21.3.5.4. Service Footprint
            21.3.5.5. Strategy Overview
                21.3.5.5.1. Marketing Strategy
                21.3.5.5.2. Service Strategy
                21.3.5.5.3. Channel Strategy
        21.3.6. Tecan Trading AG
            21.3.6.1. Overview
            21.3.6.2. Service Portfolio
            21.3.6.3. Profitability by Market Segments(Service/Channel/Country)
            21.3.6.4. Service Footprint
            21.3.6.5. Strategy Overview
                21.3.6.5.1. Marketing Strategy
                21.3.6.5.2. Service Strategy
                21.3.6.5.3. Channel Strategy
        21.3.7. Hamilton Medical AG
            21.3.7.1. Overview
            21.3.7.2. Service Portfolio
            21.3.7.3. Profitability by Market Segments(Service/Channel/Country)
            21.3.7.4. Service Footprint
            21.3.7.5. Strategy Overview
                21.3.7.5.1. Marketing Strategy
                21.3.7.5.2. Service Strategy
                21.3.7.5.3. Channel Strategy
        21.3.8. Biospherix
            21.3.8.1. Overview
            21.3.8.2. Service Portfolio
            21.3.8.3. Profitability by Market Segments(Service/Channel/Country)
            21.3.8.4. Service Footprint
            21.3.8.5. Strategy Overview
                21.3.8.5.1. Marketing Strategy
                21.3.8.5.2. Service Strategy
                21.3.8.5.3. Channel Strategy
        21.3.9. Promocell GmbH
            21.3.9.1. Overview
            21.3.9.2. Service Portfolio
            21.3.9.3. Profitability by Market Segments(Service/Channel/Country)
            21.3.9.4. Service Footprint
            21.3.9.5. Strategy Overview
                21.3.9.5.1. Marketing Strategy
                21.3.9.5.2. Service Strategy
                21.3.9.5.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Recommendations

Healthcare

Stem Cell Therapy Market

March 2024

REP-GB-1087

315 pages

Healthcare

Dehydrated Culture Media Market

November 2024

REP-GB-13985

Upcoming

Explore Healthcare Insights

View Reports
Future Market Insights

Automated Cell Culture Systems Market

Schedule a Call